Overview
Soufflé Therapeutics, a Boston, MA-based biotechnology provider of an RNA therapy platform, raised $135M in Series B financing. The round was led by Juvia Group with participation from TCG Crossover Management, BB Biotech, Fidelity Management & Research Company, Balyasny Asset Management, a Leading Sovereign Wealth Fund, Amgen Ventures, ARCH Venture Partners, Bessemer Venture Partners, Breyer Capital, The Invus Group, Janus Henderson, Leaps by Bayer, Polaris Partners, Safar Partners, TAS Partner...See more
Website
https://souffletx.com/Headquarters
Boston, MA
Upgrade to view team
View current team members and their roles
Access founders information
Request warm introductions
Funding Rounds (1)
$135.0M • Series B
Announced on 10/13/2026
Open Positions(0)
No open jobs posted for this organization yet.
Company Updates
No updates available yet.